Aurobindo Pharma to sell US-based Natrol for about Rs 4,048 crore
Hyderabad-based Aurobindo Pharma has reached a definitive agreement to sell its US subsidiary Natrol LLC to private equity firm New Mountain Capital and its affiliate Jarrow Formulas in an all-cash transaction valued at $550 mn (about Rs 4,048 crore). This would make Aurobindo a zero-debt company and also help it repay loans, analysts said. Read More
Sea change in customs clearance as govt addresses complaints over delays
In a significant relief for importers, customs clearance saw a dramatic improvement over the weekend with about three-fourths of sea